Skip to main content
. 2024 Mar 16;25(2):bbae071. doi: 10.1093/bib/bbae071

Table 3.

TTP and average dosage for delayed-IInline graphicADT, IInline graphicADT and standard IADT.

Patient001 (responsive) Patient011 (resistant)
delayed-I2ADT I2ADT IADT delayed-I2ADT I2ADT IADT
TTP (month) 120 120 115 120 120 97
Ave. CPA (mg/day) 56.6 50.4 73 45.8 52.9 81.2
Ave. LEU (mg/month) 0.94 2.52 3.3 0.51 0.06 7.1